Quest Diagnostics is at the forefront of genetics and rare disease diagnostics, offering an integrated approach to support orphan drug development and commercialization. By consolidating our market-leading capabilities, we deliver unmatched expertise and an extensive test menu to pharmaceutical partners.
Our genetic testing services span major clinical areas, including but not limited to:
Quest Diagnostics harnesses a variety of cutting-edge technologies and platforms to provide precise and actionable diagnostic insights.
Understanding the complexity of rare diseases extends beyond traditional genetic testing. Our capabilities further incorporate:
Quest Diagnostics provides a comprehensive suite of services designed to support every phase of orphan drug development, from discovery through post-market surveillance. Leveraging our expertise and capabilities, we offer innovative solutions tailored to the unique needs of orphan drug development.
Quest Diagnostics stands apart with:
White paper:
Rare disease diagnostics: Advancing orphan drug development through precision testing
Explore the challenges facing orphan drug development, from understanding disease progression to identifying and validating biomarkers, and the importance of early diagnosis.
Connect with us to explore how Quest Diagnostics can enhance your orphan drug development strategies with our advanced genetics and rare disease solutions.